|
CREB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.37736521977195E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.89960003072321E-09 |
| Normal-vs-Stage2 |
8.0526000001413E-07 |
| Normal-vs-Stage3 |
7.33190175239429E-11 |
| Normal-vs-Stage4 |
2.27559970866764E-10 |
| Stage1-vs-Stage2 |
5.632600E-01 |
| Stage1-vs-Stage3 |
6.741600E-02 |
| Stage1-vs-Stage4 |
1.207810E-02 |
| Stage2-vs-Stage3 |
4.578600E-01 |
| Stage2-vs-Stage4 |
1.829960E-01 |
| Stage3-vs-Stage4 |
4.733400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.33539870670074E-11 |
| Normal-vs-AfricanAmerican |
3.167600E-04 |
| Normal-vs-Asian |
3.00970000033374E-08 |
| Caucasian-vs-AfricanAmerican |
6.690400E-01 |
| Caucasian-vs-Asian |
4.755200E-01 |
| AfricanAmerican-vs-Asian |
3.436800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.32690525234125E-11 |
| Normal-vs-Female |
1.39749989358506E-10 |
| Male-vs-Female |
2.143400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.32309999915037E-08 |
| Normal-vs-Age(41-60Yrs) |
3.29930527342981E-11 |
| Normal-vs-Age(61-80Yrs) |
1.39690037315177E-10 |
| Normal-vs-Age(81-100Yrs) |
5.317900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.069370E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.043820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.927200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.997800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.737200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.501000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.087500E-02 |
| Classical-VS-Follicular |
3.708400E-01 |
| Classical-VS-Other |
1.618990E-01 |
| Classical-VS-Normal |
5.78279979457363E-10 |
| Tall-VS-Follicular |
3.045600E-01 |
| Tall-VS-Other |
6.163800E-01 |
| Tall-VS-Normal |
1.28619999983925E-07 |
| Follicular-VS-Other |
3.351200E-01 |
| Follicular-VS-Normal |
9.25599999979099E-08 |
| Other-VS-Normal |
8.765000E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.36369845707918E-11 |
| Normal-vs-N1 |
8.70149952092447E-10 |
| N0-vs-N1 |
1.151440E-01 |
|
|
